Cloud Banner

Medical Devices

Image

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, By Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others) - Industry Trends and Forecast to 2030.

Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market

Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Analysis and Size

The rapid rise in rise in awareness regarding endoscopic retrograde cholangiopancreatography devices is amongst the important factor expected to intensify the growth and demand for endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market. In addition, the increase in the increase in the cases of benign tumors of the pancreas and liver across the globe and vaginal cancer, along with the rise in awareness programs, are also expected to contribute to the growth in the global market over the forecast period of 2023 to 2030.

Data Bridge Market Research analyses that the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market which was USD 524.65 million in 2022, is expected to reach USD 867.96 million by 2030, and is likely to undergo a CAGR of 3.22% during the forecast period. “Cannulas” dominates the product type segment of the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market owing to the growing prevalence of biliary disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

OLYMPUS CORPORATION (Japan), CONMED Corporation (U.S.), TeleMed Systems, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.), Merit Medical Systems (U.S.), KARL STORZ SE & Co. KG (Germany), Braun Melsungen AG (Germany), BD (Becton, Dickinson and Company) (U.S.), FUJIFILM Corporation (Japan), Medtronic (Ireland), HOBBS MEDICAL, INC. (U.S.), SureCare (U.S.), Richard Wolf GmbH (Germany), PENTAX Medical (HOYA Corporation) (Japan), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Karl Storz Endoscopy-America, Inc. (U.S.), Olympus Medical Systems (Japan)

Market Opportunities

  • Significant growth potential in emerging markets
  • Collaborations and partnerships

Market Definition

An endoscopic retrograde cholangiopancreatography (ERCP) device usually utilizes a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreaticobiliary system associated disorders. Percutaneous transhepatic cholangiography (PTC) is a type of therapeutic technique used to observe the anatomy of the biliary duct.

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Dynamics

Drivers

  • Growing Prevalence of Biliary Disorders

The increasing incidence of biliary disorders such as gallstones, bile duct obstructions, and pancreatitis is driving the demand for ERCP and PTC devices for diagnosis and treatment.

  • Advancements in Technology

Technological advancements in endoscopy and imaging techniques have improved the effectiveness and safety of ERCP and PTC procedures, leading to increased adoption.

Opportunities

  • Emerging Markets

There is significant growth potential in emerging markets where there is an increasing focus on improving healthcare infrastructure and access to advanced medical technologies.

Restraints/Challenges

  • High Cost of Devices

The cost of ERCP and PTC devices can be relatively high, which can limit their adoption in certain healthcare settings with budget constraints.

  • Complications and Risks

ERCP and PTC procedures carry certain risks and complications, including bleeding, infection, and pancreatitis, which may deter some patients and physicians from opting for these procedures.

  • Regulatory Challenges

Compliance with regulatory requirements and obtaining approvals for new devices can pose challenges for manufacturers in the ERCP and PTC device market.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Scope

The global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product Type

  • Sphincterotomes
  • Lithotripter
  • Endoscopes
  •  Accessories
  • Stents
  • Cannulas
  • Forceps
  • Snares
  • Catheters
  • Guiding Wires
  • Balloons
  • Baskets
  • Others

Application

  • Jaundice
  • Stone Removal
  • Postoperative or Posttraumatic Bile Leakage
  • Pancreatitis
  • Others

End-User

  • Jaundice
  • Stone Removal
  • Postoperative or Posttraumatic Bile Leakage
  • Pancreatitis
  • Others

Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Regional Analysis/Insights

The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is analysed and market size insights and trends are provided by product type, application and end-user as referenced above.

The countries covered in the global endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

North America dominates the endoscopic retrograde cholangiopancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC) devices market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.

Asia-Pacific is the expected region in terms of growth in endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market due to rise in the prevalence of pediatric genetic diseases in this region.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Share Analysis

The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market.

Some of the major players operating in the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market are:

  • OLYMPUS CORPORATION (Japan)
  • CONMED Corporation (U.S.)
  • TeleMed Systems, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Cook (U.S.)
  • Merit Medical Systems (U.S.)
  • KARL STORZ SE & Co. KG (Germany)
  • Braun Melsungen AG (Germany)
  • BD (Becton, Dickinson and Company) (U.S.)
  • FUJIFILM Corporation (Japan)
  • Medtronic (Ireland)
  • HOBBS MEDICAL, INC. (U.S.)
  • SureCare (U.S.)
  • Richard Wolf GmbH (Germany)
  • PENTAX Medical (HOYA Corporation) (Japan)
  • Johnson & Johnson (U.S.)
  • Stryker Corporation (U.S.)
  • Smith & Nephew plc (U.K.)
  • Karl Storz Endoscopy-America, Inc. (U.S.)
  • Olympus Medical Systems (Japan)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market size will be worth USD 867.96 million by 2030.
The growth rate of the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market is 3.2% in the forecast period by 2030.
The growing prevalence of biliary disorders & advancements in technology are the growth drivers of the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market.
Product type, application, and end-use are the factors on which the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market research is based.
Major companies in the endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market are OLYMPUS CORPORATION (Japan), CONMED Corporation (U.S.), TeleMed Systems, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.), Merit Medical Systems (U.S.), KARL STORZ SE & Co. KG (Germany), Braun Melsungen AG (Germany), BD (Becton, Dickinson and Company) (U.S.), FUJIFILM Corporation (Japan), Medtronic (Ireland), HOBBS MEDICAL, INC. (U.S.), SureCare (U.S.), Richard Wolf GmbH (Germany), PENTAX Medical (HOYA Corporation) (Japan), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Karl Storz Endoscopy-America, Inc. (U.S.), Olympus Medical Systems (Japan)
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials